A New Way Forward
for Autoimmune Disease
Our Mission
We Are Nkarta
The current treatment paradigm for autoimmune disease is not good enough — a reality many of our colleagues understand firsthand as patients or caregivers themselves. This perspective shapes our sense of urgency to transform the standard of care and improve the lives of patients living with rheumatic disease.
Patients First
Our Clinical Trial Promise
Instead of asking people with serious diseases to reconstruct their lives around our studies, drug developers should be striving to design our research around their lives. Read about what we’re doing to make clinical trial opportunities more accessible and equitable.
Nature
Boosted Killer Cells Show Promise For Autoimmune Disease
“Supercharged ‘natural killer’ cells could become a potent way to reset a disordered immune system,” according to one of the world's most prestigious scientific journals.
Our Autoimmune Targets
We are dedicated to realizing the potential of natural killer (NK) cells for the treatment of autoimmune diseases. Our proprietary technology is designed to harness the inherent disease-fighting capabilities of these immune cells to act against cells that are dysfunctional, diseased or otherwise abnormal.
Follow us on Linkedin
Clarissa was laid so low by myositis, she couldn’t lift her head from her pillow. Yet despite the exhaustion wrought by her autoimmune disease, she remains somehow inexhaustible, raising five kids while working to build a community for myositis moms. It was impossible not to smile watching Clarissa shine at The Myositis Association’s Heroes in the Fight reception in St. Louis.
At Nkarta, our ultimate success depends on hearing real stories from real people navigating autoimmune disease. When you share yours, you’re informing how innovative companies pursue and measure the outcomes that matter most to you.
